FrancophonIA/ELRC3.0 huggingface dataset:
English: Exenatide ER 2 mg
Estonian: Prolongeeritult vabanev eksenatiid 2 mg
English: INFORMATION IN BRAILLE Ozempic 0.25 mg
Estonian: TEAVE BRAILLE' KIRJAS (PUNKTKIRJAS) Ozempic 0,25 mg
English: • tiredness
Estonian: • Röhatus
English: Always remove the injection needle after each injection and store the pen without a needle attached.
Estonian: Pärast igat süstet eemaldage alati süstenõel ja hoidke pen-süstlit ilma nõelata.
English: Hydrochloric acid (for pH adjustment) Sodium hydroxide (for pH adjustment) Water for injections
Estonian: Vesinikkloriidhape (pH reguleerimiseks) Naatriumhüdroksiid (pH reguleerimiseks)
English: No dose adjustment is required for patients with hepatic impairment.
Estonian: Annuse kohandamine maksakahjustusega patsientidel ei ole vajalik.
English: When to use Ozempic
Estonian: Millal tuleb Ozempic'ut kasutada
English: Please see section 4 for the warning signs of low blood sugar levels.
Estonian: Madala veresuhkru ohumärkidega tutvumiseks vt lõik 4.
English: 1 pen and 4 disposable needles (4 doses)
Estonian: 1 pen-süstel ja 4 ühekordset nõela (4 annust)
English: Rare: may affect up to 1 in 1,000 people
Estonian: Harv: võivad esineda kuni ühel inimesel 1000-st.
English: 3 pens and 12 disposable NovoFine Plus needles.
Estonian: 3 pen-süstlit ja 12 ühekordset nõela NovoFine Plus
English: Caution should be exercised in patients with a history of pancreatitis.
Estonian: Ettevaatlik tuleb olla pankreatiiti põdenud patsientide ravimisel.
English: Start by checking your pen to make sure that it contains Ozempic 1 mg, then look at the illustrations below to get to know the different parts of your pen and needle.
Estonian: Esmalt kontrollige pen-süstlit veendumaks, et see sisaldab ravimit Ozempic 1 mg, ning seejärel vaadake alltoodud jooniseid, et õppida tundma pen-süstli ja nõela erinevaid osi.
English: Caution should be exercised when using semaglutide in patients with diabetic retinopathy treated with insulin.
Estonian: Insuliiniga ravitud diabeetilise retinopaatiaga patsientide korral tuleb semaglutiidi kasutamisega olla ettevaatlik.
English: 1 mg in the dose counter must line up precisely with the dose pointer to ensure that you get a correct dose.
Estonian: Annuse loenduril valitud 1 mg peab õige annuse tagamiseks olema annuse osutiga täpselt joondatud.
English: Cardiovascular death Non-fatal stroke Non-fatal myocardial infarction
Estonian: Kardiovaskulaarne surm Surmaga mittelõppenud insult Surmaga mittelõppenud südamelihase infarkt
English: • bloating of the stomach
Estonian: • Kõhu pundumine
English: STATEMENT OF ACTIVE SUBSTANCE Each dose (0.74 ml) contains 1 mg semaglutide (1.34 mg/ml),
Estonian: TOIMEAINE SISALDUS Üks annus (0,74 ml) sisaldab 1 mg semaglutiidi (1,34 mg/ml),
English: In the phase 3a trials, mean increases of 1 to 6 beats per minute (bpm) from a baseline of 72 to 76 bpm were observed in subjects treated with Ozempic.
Estonian: IIIa faasi uuringutes täheldati Ozempic'uga ravitud patsientidel keskmist suurenemist 1…6 lööki minutis algväärtusest 72…76 lööki minutis.
English: However, when initiating treatment with Ozempic in combination with a sulfonylurea or an insulin, blood glucose self-monitoring may become necessary to adjust the dose of the sulfonylurea or the insulin to reduce the risk of hypoglycaemia (see section 4.4).
Estonian: Küll aga võib glükoosi taseme jälgimine patsiendi poolt osutuda vajalikuks sulfonüüluurea või insuliini annuse reguleerimiseks siis, kui alustatakse Ozempic-ravi kombineeritult sulfonüüluureaga või insuliiniga, et vähendada hüpoglükeemia ohtu (vt lõik 4.4).
English: PHARMACEUTICAL FORM AND CONTENTS solution for injection
Estonian: RAVIMVORM JA PAKENDI SUURUS süstelahus
English: If you do that, you might not get the intended effect of this medicine.
Estonian: Selle juhise eiramisel ei pruugi olla tagatud ravimi eeldatav toime.
English: Postnatal growth and development were evaluated in cynomolgus monkeys.
Estonian: Jaava makaakidel hinnati postnataalset kasvu ja arengut.
English: Once empty, it must be disposed of.
Estonian: Tühjaks saanud pen-süstel tuleb ära visata.
English: Each pen contains 3 ml solution, delivering 4 doses of 1 mg.
Estonian: Üks pen-süstel sisaldab 3 ml lahust, mis on mõeldud 4-ks 1 mg annuseks.
English: HbA1c at baseline was 8.8%, 8.9% and 8.9% for Ozempic 0.5 mg, Ozempic 1 mg, and placebo, respectively.
Estonian: HbA1c väärtus uuringu alguses oli 8,8%, 8,9% ja 8,9% vastavalt Ozempic 0,5 mg, Ozempic 1 mg ja platseebo rühmas.
English: Semaglutide lowered high blood glucose concentrations by stimulating insulin secretion and lowering glucagon secretion in a glucose dependent manner.
Estonian: Glükoosist sõltuv insuliini ja glükagooni sekretsioon Semaglutiid vähendab kõrgenenud vere glükoosi kontsentratsioone, stimuleerides insuliini vabastamist ja vähendades glükagooni sekretsiooni glükoosist sõltuval moel.
English: At week 30, the change in HbA1c was -1.6%, -1.5% and 0.1% for Ozempic 0.5 mg, Ozempic 1 mg, and placebo, respectively.
Estonian: 30. nädalal oli HbA1c muutus algväärtusest1,6%, -1,5% ja 0,1% vastavalt Ozempic 0,5 mg, Ozempic 1 mg ja platseebo korral.
English: Change from baseline at week 30 Body weight (kg)
Estonian: Algväärtus (keskmine) Muutus algväärtusest 30. nädalal Kehakaal (kg)
English: One pre-filled pen contains 4 mg semaglutide in 3 ml solution.
Estonian: Üks pen-süstel sisaldab 4 mg semaglutiidi 3 ml lahuses.
English: Start by checking your pen to make sure that it contains Ozempic 0.5 mg, then look at the illustrations below to get to know the different parts of your pen and needle.
Estonian: Esmalt kontrollige pen-süstlit veendumaks, et see sisaldab ravimit Ozempic 0,5 mg, ning seejärel vaadake alltoodud jooniseid, et õppida tundma pen-süstli ja nõela erinevaid osi.
English: 0.5 mg in the dose counter must line up precisely with the dose pointer to ensure that you get a correct dose.
Estonian: Annuse loenduril valitud 0,5 mg peab õige annuse tagamiseks olema annuse osutiga täpselt joondatud.
English: Diabetic retinopathy
Estonian: Diabeetiline retinopaatia
English: 0.5 mg selected
Estonian: Valitud on 0,5 mg
English: Keep the pen cap on in order to protect from light.
Estonian: Hoida pen-süstlit suletud korgiga valguse eest kaitstult.
English: 1 pre-filled pen and 4 disposable NovoFine Plus needles
Estonian: 1 pen-süstel ja 4 ühekordset nõela NovoFine Plus
English: STATEMENT OF ACTIVE SUBSTANCE Each dose (0.37 ml) contains 0.5 mg semaglutide (1.34 mg/ml),
Estonian: TOIMEAINE SISALDUS Üks annus (0,37 ml) sisaldab 0,5 mg semaglutiidi (1,34 mg/ml),
English: Semaglutide delays the rate of gastric emptying as assessed by paracetamol pharmacokinetics during a standardised meal test. Paracetamol AUC0-60min and Cmax were decreased by 27% and 23%, respectively, following concomitant use of semaglutide 1 mg.
Estonian: Paratsetamooli AUC0-60 min ja Cmax vähenesid vastavalt 27% ja 23% pärast semaglutiidi 1 mg samaaegset manustamist.
English: INFORMATION IN BRAILLE Ozempic 0.5 mg
Estonian: TEAVE BRAILLE' KIRJAS (PUNKTKIRJAS) Ozempic 0,5 mg
English: Start by checking your pen to make sure that it contains Ozempic 0.25 mg, then look at the illustrations below to get to know the different parts of your pen and needle.
Estonian: Esmalt kontrollige pen-süstlit veendumaks, et see sisaldab ravimit Ozempic 0,25 mg, ning seejärel vaadake alltoodud jooniseid, et õppida tundma pen-süstli ja nõela erinevaid osi.
English: One pre-filled pen contains 2 mg semaglutide* in 1.5 ml solution.
Estonian: Üks pen-süstel sisaldab 2 mg semaglutiidi* 1,5 ml lahuses.
English: 0.25 mg in the dose counter must line up precisely with the dose pointer to ensure that you get a correct dose.
Estonian: Annuse loenduril valitud 0,25 mg peab õige annuse tagamiseks olema annuse osutiga täpselt joondatud.
English: One pre-filled pen contains 2 mg semaglutide in 1.5 ml solution.
Estonian: Üks pen-süstel sisaldab 2 mg semaglutiidi 1,5 ml lahuses.
English: Each dose contains 1 mg of semaglutide in 0.74 ml.
Estonian: Üks annus sisaldab 1 mg semaglutiidi 0,74 ml lahuses.
English: NAME OF THE MEDICINAL PRODUCT Ozempic 0.25 mg solution for injection in pre-filled pen Ozempic 0.5 mg solution for injection in pre-filled pen Ozempic 1 mg solution for injection in pre-filled pen
Estonian: RAVIMPREPARAADI NIMETUS Ozempic 0,25 mg süstelahus pen-süstlis Ozempic 0,5 mg süstelahus pen-süstlis Ozempic 1 mg süstelahus pen-süstlis
English: At week 30, the change in HbA1c was -1.3%, -1.8% and0.4% for Ozempic 0.5 mg, Ozempic 1 mg, and placebo, respectively.
Estonian: 30. nädalal oli HbA1c muutus -1,3%, -1,8% ja -0,4% vastavalt Ozempic 0,5 mg, Ozempic 1 mg ja platseebo rühmas.
English: STATEMENT OF ACTIVE SUBSTANCE Each dose (0.19 ml) contains 0.25 mg semaglutide (1.34 mg/ml),
Estonian: TOIMEAINE SISALDUS Üks annus (0,19 ml) sisaldab 0,25 mg semaglutiidi (1,34 mg/ml),
English: • less appetite
Estonian: • Söögiisu vähenemine
English: You may get side effects such as feeling sick (nausea).
Estonian: Teil võib tekkida kõrvaltoimeid, nagu näiteks iiveldus.
English: The incidence of discontinuation of treatment due to adverse events was 6.1% and 8.7% for patients treated with semaglutide 0.5 mg and 1 mg, respectively, versus 1.5% for placebo.
Estonian: Kõrvaltoimete tõttu katkestasid ravi 1,5% patsientidest platseebogrupis ning 6,1% ja 8,7% patsientidest, keda raviti vastavalt semaglutiidi annustega 0,5 mg ja 1 mg. Kõige sagedasem katkestamist põhjustanud kõrvaltoime oli seedetrakti häire.
English: Hold the dose button down until the dose counter shows 0.
Estonian: Vajutage annusenuppu ja hoidke seda all, kuni annuse loendur jõuab väärtuseni 0.
English: Count slowly:
Estonian: Loenda aeglaselt:
English: Hypoglycaemiaa when used with other OADs
Estonian: Hüpoglükeemiaa, kui kasutatakse koos muude diabeediravimitega
English: Keep the pen cap on when the pen is not in use in order to protect it from light.
Estonian: Kui pen-süstel pole kasutusel, peab see olema korgiga suletud, et hoida seda valguse eest kaitstult.
English: One pre-filled pen contains 4 mg semaglutide* in 3.0 ml solution.
Estonian: Üks pen-süstel sisaldab 4 mg semaglutiidi* 3,0 ml lahuses.
English: The dose selector clicks differently when turned forwards, backwards or past 1 mg. Do not count the pen clicks.
Estonian: Dosaator klõpsatab edasi, tagasi ja üle 1 mg keeramisel erinevalt.
English: Time since randomisation (week) Ozempic 0.5 mg Sitagliptin
Estonian: Aeg randomiseerimisest (nädal) Ozempic 0,5 mg Sitagliptiin
English: Ozempic 0.25 mg solution for injection: Each pre-filled pen contains 1.5 ml of solution, delivering 4 doses of 0.25 mg.
Estonian: Ozempic 0,25 mg süstelahus: üks pen-süstel sisaldab 1,5 ml lahust, mis on mõeldud 4-ks 0,25 mg annuseks.
English: How Ozempic is given
Estonian: Kuidas Ozempic'ut manustatakse
English: Ozempic 1 mg solution for injection: Each pre-filled pen contains 3 ml of solution, delivering 4 doses of 1 mg.
Estonian: Ozempic 1 mg süstelahus: üks pen-süstel sisaldab 3 ml lahust, mis on mõeldud 4-ks 1 mg annuseks.
English: Ozempic 0.5 mg solution for injection: Each pre-filled pen contains 1.5 ml of solution, delivering 4 doses of 0.5 mg.
Estonian: Ozempic 0,5 mg süstelahus: üks pen-süstel sisaldab 1,5 ml lahust, mis on mõeldud 4-ks 0,5 mg annuseks.
English: Preclinical data reveal no special hazards for humans based on conventional studies of safety pharmacology, repeat-dose toxicity or genotoxicity.
Estonian: Farmakoloogilise ohutuse, korduvtoksilisuse ja genotoksilisuse prekliinilised uuringud ei ole näidanud kahjulikke toimeid inimesele.
English: Hypoglycaemia defined as severe (requiring the assistance of another person) or symptomatic in combination with a blood glucose <3.1 mmol/L
Estonian: Tõsine (vajalik on teise isiku abi) hüpoglükeemia või sümptomaatiline hüpoglükeemia kombinatsioonis veresuhkruga <3,1 mmol/l b) Diabeetilise retinopaatia komplikatsioonideks on: retinaalne fotokoagulatsioon, ravi intravitreaalsete ainetega,
English: Change from baseline at week 30 Difference from placebo [95% CI]
Estonian: Algväärtus (keskmine) Muutus algväärtusest 30. nädalal Erinevus glargiin-insuliinist [95% CI]
English: Always use the dose counter and the dose pointer to see that 1 mg has been selected before injecting this medicine.
Estonian: Enne selle ravimi süstimist kontrollige alati annuse loenduri ja annuse osuti abil, et olete valinud 1 mg.
English: HbA1c at baseline was 8.2%, 8.4% and 8.4% for Ozempic 0.5 mg, Ozempic 1 mg, and placebo, respectively.
Estonian: HbA1c väärtus uuringu alguses oli 8,2%, 8,4% ja 8,4% vastavalt Ozempic 0,5 mg, Ozempic 1 mg ja platseebo rühmas.
English: The risk of hypoglycaemia can be lowered by reducing the dose of sulfonylurea or insulin when initiating treatment with semaglutide (see section 4.8).
Estonian: Semaglutiidravi alustamisel saab hüpoglükeemia riski vähendada sulfonüüluurea või insuliini annuse vähendamisega (vt lõik 4.8).
English: EXPIRY DATE
Estonian: Väljavoolu tähis
English: Exposure of ethinylestradiol was not affected; an increase of 20% was observed for levonorgestrel exposure at steady state.
Estonian: Täheldati levonorgestreeli püsikontsentratsiooni suurenemist 20%.
English: How to handle a blocked needle
Estonian: Ummistunud nõela kõrvaldamine
English: The dose selector clicks differently when turned forwards, backwards or past 0.5 mg. Do not count the pen clicks.
Estonian: Dosaator klõpsatab edasi, tagasi ja üle 0,5 mg keeramisel erinevalt.
English: Each dose contains 0.25 mg of semaglutide in 0.19 ml.
Estonian: Üks annus sisaldab 0,25 mg semaglutiidi 0,19 ml lahuses.
English: Patients (%) achieving HbA1c <7% FPG (mmol/L)
Estonian: Patiendid (%) kes saavutasid HbA1c <7%
English: Each pen contains 1.5 ml of solution, delivering 4 doses of 0.25 mg.
Estonian: Üks pen-süstel sisaldab 1,5 ml lahust, mis on mõeldud 4-ks 0,25 mg annuseks.
English: • being sick (vomiting)
Estonian: • Kõhugaasid (kõhupuhitus)
English: -5.1 [-6.1, -4.0]a p <0.0001 (2-sided) for superiority
Estonian: -5,1 [-6,1, -4,0]a p <0001 (kahepoolne) paremus (superiority)
English: Table 5 SUSTAIN 3: Results at week 56
Estonian: Tulemused 56. nädalal
English: Each dose contains 0.5 mg of semaglutide in 0.37 ml.
Estonian: Üks annus sisaldab 0,5 mg semaglutiidi 0,37 ml lahuses.
English: Ozempic is to be injected subcutaneously in the abdomen, in the thigh or in the upper arm.
Estonian: Ozempic süstitakse subkutaanselt kõhtu, reide või õlavarde.
English: Age had no effect on the pharmacokinetics of semaglutide based on data from phase 3a studies including patients of 20-86 years of age.
Estonian: Andmete põhjal, mis pärinevad IIIa faasi uuringutest, kuhu kaasati 20…86 aasta vanused patsiendid, ei mõjutanud vanus semaglutiidi farmakokineetikat.
English: Body weight has an effect on the exposure of semaglutide.
Estonian: Kehakaal mõjutab semaglutiidi plasmakontrsentratsiooni.
English: NAME OF THE MEDICINAL PRODUCT AND ROUTE OF ADMINISTRATION Ozempic 1 mg injection semaglutide subcutaneous use
Estonian: RAVIMPREPARAADI NIMETUS JA MANUSTAMISTEE Ozempic 1 mg süstevedelik semaglutidum s.c.
English: Always use the dose counter and the dose pointer to see that 0.25 mg has been selected before injecting this medicine.
Estonian: Enne selle ravimi süstimist kontrollige alati annuse loenduri ja annuse osuti abil, et olete valinud 0,25 mg. Ärge loendage pen-süstli klõpsatusi.
English: How to store Ozempic
Estonian: Kuidas Ozempic'ut säilitada
English: -3.6 [-4.7, -2.4]a p <0.0001 (2-sided) for superiority
Estonian: -3,6 [-4,7, -2,4]a p <0,0001 (kahepoolne) paremus (superiority)
English: Ozempic 0.25 mg solution for injection
Estonian: Ozempic 0,25 mg süstelahus
English: -4.2 [-4.9, -3.5]a ap <0.0001 (2-sided) for superiority
Estonian: -4,2 [-4,9, -3,5]a p <0,0001 (kahepoolne) paremus (superiority)
English: Each pen contains 1.5 ml of solution, delivering 4 doses of 0.5 mg.
Estonian: Üks pen-süstel sisaldab 1,5 ml lahust, mis on mõeldud 4-ks 0,5 mg annuseks.
English: If there is not enough solution left in your pen for a full dose, do not use it. Use a new Ozempic pen.
Estonian: Kui pen-süstlisse pole jäänud piisavalt lahust vajaliku annuse manustamiseks, ärge seda kasutage.
English: Always use the dose counter and the dose pointer to see that 0.5 mg has been selected before injecting this medicine.
Estonian: Enne selle ravimi süstimist kontrollige alati annuse loenduri ja annuse osuti abil, et olete valinud 0,5 mg.
English: NAME OF THE MEDICINAL PRODUCT AND ROUTE OF ADMINISTRATION Ozempic 0.25 mg injection semaglutide subcutaneous use
Estonian: RAVIMPREPARAADI NIMETUS JA MANUSTAMISTEE Ozempic 0,25 mg süstevedelik semaglutidum s.c.
English: NAME OF THE MEDICINAL PRODUCT Ozempic 1 mg solution for injection in pre-filled pen semaglutide
Estonian: RAVIMPREPARAADI NIMETUS Ozempic 1 mg süstelahus pen-süstlis semaglutidum
English: In lactating rats, semaglutide was excreted in milk.
Estonian: Imetavatel rottidel eritus semaglutiid rinnapiima.
English: Gastro-oesophageal reflux disease Eructation Flatulence
Estonian: Gastroösofagaalne reflukshaigus Röhitsus
English: No episodes of severe hypoglycaemia were observed when semaglutide was used as monotherapy.
Estonian: Semaglutiidi monoteraapia korral ei ilmnenud ühtegi tõsise hüpoglükeemia juhtu.
English: Ozempic 1 mg solution for injection in pre-filled pen semaglutide
Estonian: Ozempic 1 mg süstelahus pen-süstlis semaglutiid (semaglutidum)
English: With semaglutide, the insulin secretion rate in patients with type 2 diabetes was comparable to that of healthy subjects.
Estonian: Semaglutiidi saavatel 2. tüüpi diabeediga patisentidel oli insuliini vabastamise kiirus võrreldav tervete uuritavatega (joonis 1).
English: -3.6c [-4.3, -2.8]a p <0.0001 (2-sided) for superiority b
Estonian: -3,8 [-4,6, -3,0]a p <0,0001 (kahepoolne) paremus (superiority)
English: Uncommon Rare
Estonian: Ununenud annus
English: Ozempic can be administered with needles up to a length of 8 mm.
Estonian: Ozempic'ut saab manustada nõeltega, mille pikkus on kuni 8 mm. Pen-süstel on ette nähtud kasutamiseks ühekordsete nõeltega NovoFine või NovoTwist.
English: Ozempic 0.5 mg solution for injection
Estonian: Ozempic 0,5 mg süstelahus
English: • indigestion
Estonian: • Kõhukinnisus
English: NAME OF THE MEDICINAL PRODUCT Ozempic 0.5 mg solution for injection in pre-filled pen semaglutide
Estonian: RAVIMPREPARAADI NIMETUS Ozempic 0,5 mg süstelahus pen-süstlis semaglutidum
English: NAME OF THE MEDICINAL PRODUCT Ozempic 0.25 mg solution for injection in pre-filled pen semaglutide
Estonian: RAVIMPREPARAADI NIMETUS Ozempic 0,25 mg süstelahus pen-süstlis semaglutidum
English: NAME OF THE MEDICINAL PRODUCT AND ROUTE OF ADMINISTRATION Ozempic 0.5 mg injection semaglutide subcutaneous use
Estonian: RAVIMPREPARAADI NIMETUS JA MANUSTAMISTEE Ozempic 0,5 mg süstevedelik semaglutidum s.c.
English: 0.5 mg left
Estonian: 0,5 mg
English: Ozempic 0.25 mg solution for injection in pre-filled pen semaglutide
Estonian: Ozempic 0,25 mg süstelahus pen-süstlis semaglutiid (semaglutidum)
English: Talk to your doctor if you have any questions or concerns.
Estonian: Kui teil on küsimusi või kahtlusi, pidage nõu oma arstiga.
English: The dose selector clicks differently when turned forwards, backwards or past 0.25 mg. Do not count the pen clicks.
Estonian: Ainult annuse loendur ja annuse osuti näitavad, et valitud on 0,25 mg. Dosaator klõpsatab edasi, tagasi ja üle 0,25 mg keeramisel erinevalt.
English: -2.3b [-3.0, -1.5]a
Estonian: -2,3 [-3,1, -1,6]a
English: Ozempic 0.5 mg solution for injection in pre-filled pen semaglutide
Estonian: Ozempic 0,5 mg süstelahus pen-süstlis semaglutiid (semaglutidum)
English: Cholelithiasis
Estonian: Kehakaal
English: • fast pulse
Estonian: • Kõhuvalu
English: Favours placebo
Estonian: Eelis platseebol
English: Ozempic 1 mg solution for injection
Estonian: Ozempic 1 mg süstelahus
English: Do not take a double dose to make up for a forgotten dose.
Estonian: Ärge süstige kahekordset annust, kui annus jäi eelmisel korral manustamata.
English: Talk to your doctor, pharmacist or nurse before using this medicine.
Estonian: Hoiatused ja ettevaatusabinõud Enne selle ravimi kasutamist pidage nõu oma arsti, apteekri või meditsiiniõega.
English: Instructions on how to use Ozempic 0.25 mg solution for injection in pre-filled pen
Estonian: Ozempic 0,25 mg süstelahus pen-süstlis kasutusjuhend
English: • weight loss
Estonian: • Kehakaalu vähenemine
English: Your pen is a pre-filled dial-a-dose pen.
Estonian: Pen-süstel on süstevahend, mis võimaldab valida annuse suurust.
English: Pen cap
Estonian: PEN-SÜSTLI SILT
English: Semaglutide exposure increased in a dose proportional manner for doses of 0.5 mg and 1 mg.
Estonian: Annuste 0,5 mg ja 1 mg korral suurenes semaglutiidi plasmakontrsentratsioon annusega proportsionaalselt.
English: Ozempic 0.5 mg vs dulaglutide 0.75 mg c Ozempic 1 mg vs dulaglutide 1.5 mg
Estonian: -2,3b [-3,0; -1,5]a -3,6c [-4,3; -2,8]a ap <0,0001 (kahepoolne) paremus (superiority) b Ozempic 0,5 mg vs dulaglutiid 0,75 mg c Ozempic 1 mg vs dulaglutiid 1,5 mg
English: Further information on NeuroBloc can be found on the Agency's website ema.europa.eu/Find medicine/Human medicines/European Public Assessment Reports.
Estonian: Lisateave NeuroBloci kohta on ameti veebilehel ema.europa.eu/Find medicine/Human medicines/European Public Assessment Reports.
English: What measures are being taken to ensure the safe and effective use of NeuroBloc?
Estonian: Mis meetmed võetakse, et tagada NeuroBloci ohutu ja efektiivne kasutamine?
English: The European Medicines Agency decided that NeuroBloc's benefits are greater than its risks and it can be authorised for use in the EU.
Estonian: Euroopa Ravimiamet otsustas, et NeuroBloci kasulikkus on suurem kui sellega kaasnevad riskid ja et ravimi kasutamise võib ELis heaks kiita.
English: Other information about NeuroBloc
Estonian: Muu teave NeuroBloci kohta
English: NeuroBloc (botulinum toxin type B) EMA/356522/2018
Estonian: Neurobloc (B-tüübi botulismitoksiin) EMA/356522/2018
English: The dose and number of injections depend on the patient's response.
Estonian: Annus ja süstimiskordade arv sõltuvad patsiendi ravivastusest.
English: Effectiveness was measured by looking at the change in symptoms (severity, pain and disability) after four weeks, measured using the Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS).
Estonian: Efektiivsuse mõõtmiseks vaadeldi sümptomite (raskusaste, valu ja funktsioonihäire) muutust 4 nädala pärast, kasutades hindamisskaalat Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS).
English: Most patients who had a response to NeuroBloc by the fourth week had returned to their original condition 12 to 16 weeks after the injection.
Estonian: Enamikul patsientidest, kellel tekkis 4. nädalaks NeuroBlociga ravivastus, oli algseis taastunud 12-16 nädala jooksul pärast süstimist.
English: NeuroBloc must not be used in patients with other neuromuscular (nerve and muscle) disorders.
Estonian: NeuroBloci ei tohi kasutada muude neuromuskulaarsete (närvide ja lihaste) häiretega patsientidel.
English: NeuroBloc received a marketing authorisation valid throughout the EU on 22 January 2001.
Estonian: NeuroBloci müügiluba, mis kehtib kogu Euroopa Liidus, anti 22. jaanuaril 2001.
English: As for all medicines, data on the use of NeuroBloc are continuously monitored.
Estonian: Nagu kõigi ravimite puhul, teostatakse NeuroBloci kasutamise kohta pidevat järelevalvet.
English: Recommendations and precautions to be followed by healthcare professionals and patients for the safe and effective use of NeuroBloc have been included in the summary of product characteristics and the package leaflet.
Estonian: NeuroBloci ohutu ja efektiivse kasutamise soovitused ja ettevaatusmeetmed tervishoiutöötajatele ja patsientidele on lisatud ravimi omaduste kokkuvõttesse ja pakendi infolehele.
English: Side effects reported with NeuroBloc are carefully evaluated and any necessary action taken to protect patients.
Estonian: NeuroBloci kõrvalnähte hinnatakse hoolikalt ja patsientide kaitseks rakendatakse vajalikke meetmeid.
English: What is NeuroBloc and what is it used for?
Estonian: Mis on NeuroBloc ja milleks seda kasutatakse?